US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

63.62

+1.221.96%

Volume:16.81K

Turnover:1.07M

Market Cap:274.84M

PE:20.81

High:63.75

Open:63.03

Low:63.03

Close:62.40

52wk High:64.10

52wk Low:39.10

Shares:4.32M

Float Shares:4.32M

Volume Ratio:1.05

T/O Rate:0.39%

Dividend:1.53

Dividend Rate:2.40%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Revolution Medicines Q2 FY26 Net Loss Widens to $644.4 Million; R&D Expenses Rise to $394.9 Million

Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

THOMSON REUTERS

Guardant Health is Maintained at Overweight by Morgan Stanley

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Simply Wall St.

Revolution Medicines Inc Expected to Post a Loss of $1.98 a Share - Earnings Preview

Analysts Conflicted on These Healthcare Names: Guardant Health (GH) and Cardinal Health (CAH)

Wall Street Analysts Are Bullish on Top Healthcare Picks

Brightspring Health Services Inc : Raymond James Cuts Target Price to $75 from $80

THOMSON REUTERS

BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG

Jefferies Cuts Ipsen to 'underperform' on Somatuline Competition Risk

Tax Authorities Target Medical Device Firms Over Inflated Invoicing Practices, Recover Billions

Brightspring Health Services Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

BrightSpring Health selloff appears overdone, says Mizuho

Guardant Health Shares Climb Following Outlook Raise

FDA Priority Review For Daraxonrasib Might Change The Case For Investing In Revolution Medicines (RVMD)

Simply Wall St.

RBC Raises Price Target on Guardant Health to $200 From $185, Keeps Outperform Rating

MT Newswires Live

Roivant Sciences price target raised to $35 from $31.50 at BofA

Guardant Health is Maintained at Buy by BTIG

BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate

Benzinga Earnings

Brightspring Health Services Q2 Net Income USD 87 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PTH/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":63.6213,"timestamp":1787675467456,"preClose":62.3981,"halted":0,"volume":16809,"delay":0,"changeRate":0.019603160993684077,"floatShares":4320000,"shares":4320000,"eps":3.057033,"marketStatus":"Trading","change":1.2232,"latestTime":"08-25 12:39:30 EDT","open":63.03,"high":63.75,"low":63.03,"amount":1068855.39852,"amplitude":0.011539,"askPrice":63.69,"askSize":300,"bidPrice":63.58,"bidSize":281,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":62.3981,"sharesOutstanding":2480000,"nav":62.98271,"aum":273974788.5,"dividendRate":0.02403,"bidAskSpread":0.002049,"postHourTrading":{"tag":"盘后","latestPrice":62.41,"preClose":62.3981,"latestTime":"19:30 EDT","volume":14,"amount":872.8867,"timestamp":1787614203296,"change":0.0119,"changeRate":0.000191,"amplitude":0},"volumeRatio":1.048835,"impliedVol":0.1606,"impliedVolPercentile":0.7928},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4320000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.048835,"shares":4320000,"dividePrice":1.5288,"high":63.75,"amplitude":0.011539,"preClose":62.3981,"low":63.03,"week52Low":39.1,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":63.6213,"committee":-0.032702,"eps":3.057033,"divideRate":0.02403,"volume":16809,"delay":0,"ttmEps":3.057033,"open":63.03,"prevYearClose":49.701,"prevWeekClose":62.9761,"prevMonthClose":58.0963,"prevQuarterClose":59.76,"fiveDayClose":60.7585,"twentyDayClose":57.983,"sixtyDayClose":51.9608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657057882","title":"Revolution Medicines Q2 FY26 Net Loss Widens to $644.4 Million; R&D Expenses Rise to $394.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657057882","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657057882?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:17","pubTimestamp":1785961029,"startTime":"0","endTime":"0","summary":"Revolution Medicines Q2 FY26 net loss widens to $644.4 million; R&D expenses rise to $394.9 millionRevolution Medicines posted a GAAP net loss of $644.4 million for Q2 2026, widening from a $247.8 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL46m7gf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","IE00BKPKM429.USD","SG9999014039.USD","IE00B4R5TH58.HKD","LU2095319765.USD","IE00BN0W2W23.USD","IDNA","IE00BJJMRZ35.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","LU0320765992.SGD","IE00BGHQF748.EUR","IE00B2B36J28.USD","IE00B3QW5Z07.USD","PBE","IE00BJT1NW94.SGD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4585","LU2210150020.SGD","SG9999014021.USD","IE0009354923.USD","IHE","LU0889565916.HKD","BK4007","SG9999014013.SGD","CANC","RVMD","NDAQ","BBH","BCDF","IE0009355771.USD","IE00BN0W2T93.GBP","RPRX","PTH","IE00BFTCPJ56.SGD","BK4112","LU2210149790.SGD","LU0109394709.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657527610","title":"Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2657527610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657527610?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:02","pubTimestamp":1785960120,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA9FY8WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CANC","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139","LU0320765992.SGD","IE00B4R5TH58.HKD","BBH","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE0009354923.USD","IE0009355771.USD","IE00B2B36J28.USD","IDNA","PTH","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656556059","title":"Guardant Health is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2656556059","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656556059?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:44","pubTimestamp":1785847440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","EKG","BK4551","PTH","GNMX","GH","LU0889565916.HKD","LU0109394709.USD","BK4585","BK4588","LU0320765992.SGD","BK4196","HELX","FFOX","GNOM","BK4535","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656753914","title":"Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open","url":"https://stock-news.laohu8.com/highlight/detail?id=2656753914","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656753914?lang=en_us&edition=fundamental","pubTime":"2026-08-04 15:22","pubTimestamp":1785828122,"startTime":"0","endTime":"0","summary":"Guardant Health filed a universal shelf registration statement, allowing it to issue various securities in the future.\nThe filing gives the company flexibility to raise capital through debt, equity, or hybrid instruments as needed.\nThis development could be used to support future financing, potential acquisitions, or balance sheet adjustments.\n\nGuardant Health, listed as NasdaqGS:GH, now has formal flexibility to raise funds through a range of securities. The stock last closed at $158.83 and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-filed-a-shelf-registration-to-keep-future","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-filed-a-shelf-registration-to-keep-future","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","LU0320765992.SGD","HELX","BK4588","GNOM","LU0889565916.HKD","GH","GNMX","FFOX","EKG","PTH","LFSC","BK4551","BK4535","BK4585","GDOC","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588975","title":"Revolution Medicines Inc Expected to Post a Loss of $1.98 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588975","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588975?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:55","pubTimestamp":1785801305,"startTime":"0","endTime":"0","summary":"Revolution Medicines Inc <RVMD.OQ> expected to post a loss of $1.98 a share - Earnings PreviewRevolution Medicines IncRVMD.OQRVMD.Ois expected to  show a rise in quarterly revenue when it reports  res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4402SQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","RVMD","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BBH","CANC","IDNA","PTH","LU0889565916.HKD","IE0002141913.USD","IE00BJT1NW94.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656697372","title":"Analysts Conflicted on These Healthcare Names: Guardant Health (GH) and Cardinal Health (CAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656697372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656697372?lang=en_us&edition=fundamental","pubTime":"2026-08-03 22:00","pubTimestamp":1785765628,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Guardant Health (GH) and Cardinal Health (CAH). Gu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-guardant-health-gh-and-cardinal-health-cah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-guardant-health-gh-and-cardinal-health-cah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","CAH","LU1880398554.USD","LU1267930227.SGD","BK4581","LU0889566641.SGD","BK4196","LABU","GH","GNOM","GNMX","SG9999001440.SGD","LU1983299246.USD","LU0006061336.USD","LU1267930490.SGD","LU0109394709.USD","LU0310799852.SGD","LU1267930813.SGD","LU1571399168.USD","PTH","LFSC","GDOC","XLV","BK4175","LU0889565916.HKD","LU0128525689.USD","LU0052756011.USD","LU0320765992.SGD","LU0162691827.USD","HELX","BK4535","HCSG","EKG","LU0128526141.USD","LU0310800965.SGD","BK4585","FFOX","LU0154236417.USD","LU1880398471.USD","LU0792757196.USD","LU0211328371.USD","XBI","BK4551","BK4137","LU0072461881.USD","LU0211327993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656648372","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2656648372","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656648372?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:50","pubTimestamp":1785765023,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BrightSpring Health Services, Inc. (BTSG), Monte Ros...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-270?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-270?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","LU2468319806.SGD","LU2089984988.USD","PTH","PSCH","LU2324357040.USD","BTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656737143","title":"Brightspring Health Services Inc : Raymond James Cuts Target Price to $75 from $80","url":"https://stock-news.laohu8.com/highlight/detail?id=2656737143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656737143?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:13","pubTimestamp":1785755617,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44016O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","PTH","BK4196","LU2468319806.SGD","BTSG","LU2324357040.USD","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656322698","title":"BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2656322698","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656322698?lang=en_us&edition=fundamental","pubTime":"2026-08-03 17:11","pubTimestamp":1785748260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BTSG/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU2089984988.USD","BK4196","PSCH","LU2324357040.USD","PTH","BTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656252843","title":"Jefferies Cuts Ipsen to 'underperform' on Somatuline Competition Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2656252843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656252843?lang=en_us&edition=fundamental","pubTime":"2026-08-03 15:00","pubTimestamp":1785740403,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk** Jefferies downgrades French pharma firm IpsenIPN.PAto \"underperform\" from \"neutral,\" citing  long-term risks to its Somatul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL6N4400DH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","CANC","RVMD","BK4139","IE0009355771.USD","IDNA","IE0009354923.USD","LU0320765992.SGD","IE00BFTCPJ56.SGD","BBH","PTH","LU0109394709.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164799308","title":"Tax Authorities Target Medical Device Firms Over Inflated Invoicing Practices, Recover Billions","url":"https://stock-news.laohu8.com/highlight/detail?id=1164799308","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164799308?lang=en_us&edition=fundamental","pubTime":"2026-08-01 16:30","pubTimestamp":1785573029,"startTime":"0","endTime":"0","summary":"China's tax authorities have intensified scrutiny on the medical device sector, launching a campaign against widespread invoice fraud and fabricated transactions. On July 28, 2026, the State...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","RSPH","09996","LNGR","MEDX","BK1100","BK1574","GDOC","AGNG","HART","MDEV","PTH","IEIH","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656395031","title":"Brightspring Health Services Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656395031","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656395031?lang=en_us&edition=fundamental","pubTime":"2026-08-01 03:06","pubTimestamp":1785524803,"startTime":"0","endTime":"0","summary":"Brightspring Health Services Inc reports results for the quarter ended June 30 - Earnings SummaryBrightspring Health Services IncBTSG.OQreported quarterly adjusted earnings of 45 cents per share for t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X2ZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","PSCH","LU2468319806.SGD","PTH","BK4196","LU2324357040.USD","BTSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656957543","title":"BrightSpring Health selloff appears overdone, says Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2656957543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656957543?lang=en_us&edition=fundamental","pubTime":"2026-08-01 02:50","pubTimestamp":1785523834,"startTime":"0","endTime":"0","summary":"Mizuho reiterated an Outperform rating and $86 price target on BrightSpring Health (BTSG), noting the stock is down sharply following Q2 results as...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/brightspring-health-selloff-appears-overdone-says-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/brightspring-health-selloff-appears-overdone-says-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","BK4196","GSIB","BTSG","MFG","LU2468319806.SGD","LU2089984988.USD","LU2324357040.USD","BK4207","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655885398","title":"Guardant Health Shares Climb Following Outlook Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2655885398","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655885398?lang=en_us&edition=fundamental","pubTime":"2026-07-31 23:54","pubTimestamp":1785513240,"startTime":"0","endTime":"0","summary":"Shares of Guardant Health are trading higher after the company raised its full-year revenue outlook and reported higher-than-expected sales during the second quarter.The stock rose 6.1%, to $161.69, o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","LU0889565916.HKD","GNMX","BK4585","PTH","BK4196","HELX","BK4588","LU0109394709.USD","GDOC","GH","EKG","FFOX","GNOM","LFSC","LU0320765992.SGD","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655736076","title":"FDA Priority Review For Daraxonrasib Might Change The Case For Investing In Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655736076","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655736076?lang=en_us&edition=fundamental","pubTime":"2026-07-31 23:13","pubTimestamp":1785510787,"startTime":"0","endTime":"0","summary":"Revolution Medicines announced that the FDA has accepted for review its New Drug Application for daraxonrasib, an oral RAS(ON) multi-selective inhibitor, in previously treated metastatic pancreatic ductal adenocarcinoma, supported by the positive Phase 3 RASolute 302 trial showing improved survival, progression-free survival and quality of life versus standard chemotherapy.\nThe therapy’s inclusion in multiple high-priority U.S. and European regulatory programs, including the FDA...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/fda-priority-review-for-daraxonrasib-might-change-the-case-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rvmd/revolution-medicines/news/fda-priority-review-for-daraxonrasib-might-change-the-case-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B2B36J28.USD","IE0002141913.USD","BK4512","PTH","LU1854104046.USD","BK4141","BBH","LU2298322129.HKD","BK4588","ON","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU1978683503.SGD","BK4605","IE00B4R5TH58.HKD","LU1861214812.USD","LU0348723411.USD","LU1983260115.SGD","LU2357305700.SGD","IE00BFMHRM44.USD","IDNA","LU1861220033.SGD","LU1854103824.USD","LU0724618433.USD","LABU","IE00BD6J9T35.USD","IE00BJJMRZ35.SGD","LU2360107325.USD","IE0009355771.USD","LU1548497426.USD","LU0889565916.HKD","LU0124384867.USD","BK4139","RVMD","CANC","LU0109394709.USD","LU0320765992.SGD","LU1861219969.SGD","IE00BZ199S13.USD","LU1720051017.SGD","IE0009354923.USD","LU1720051108.HKD","BK4585","LU1861215975.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655912361","title":"RBC Raises Price Target on Guardant Health to $200 From $185, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2655912361","media":"MT Newswires Live","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655912361?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:16","pubTimestamp":1785503760,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $191.09, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GDOC","BK4588","BK4196","GNMX","GH","LU0320765992.SGD","BK4551","BK4535","PTH","FFOX","LFSC","LU0889565916.HKD","GNOM","HELX","LU0109394709.USD","BK4585","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655369371","title":"Roivant Sciences price target raised to $35 from $31.50 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2655369371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655369371?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:37","pubTimestamp":1785501458,"startTime":"0","endTime":"0","summary":"BofA raised the firm’s price target on Roivant Sciences (ROIV) to $35 from $31.50 and keeps a Neutral rating on the shares. The firm sees balanced ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-35-from-31-50-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-35-from-31-50-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","ROIV","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655350944","title":"Guardant Health is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2655350944","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655350944?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:39","pubTimestamp":1785494340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","PTH","FFOX","GNOM","LFSC","BK4585","BK4535","LU0889565916.HKD","HELX","BK4551","LU0320765992.SGD","GDOC","LU0109394709.USD","GH","BK4588","BK4196","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655529043","title":"BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655529043","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655529043?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:01","pubTimestamp":1785492070,"startTime":"0","endTime":"0","summary":"BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.40 by 12.5 percent. This is a 104.55 percent increase over earnings of $0.22 per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60830358/brightspring-health-q2-adj-eps-0-45-beats-0-40-estimate-sales-3-873b-beat-3-658b-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","BTSG","LU2324357040.USD","PSCH","LU2468319806.SGD","BK4196","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655352982","title":"Brightspring Health Services Q2 Net Income USD 87 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655352982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655352982?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:00","pubTimestamp":1785492001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nPLX52K4SS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","LU2468319806.SGD","BK4196","BTSG","PSCH","PTH","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}